My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 354

    1.

    Additive effect of unoprostone and latanoprost in patients with elevated intraocular pressure.

    Aung T, Chew PT, Oen FT, Chan YH, Thean LH, Yip L, Lim BA, Soh J, Seah SK.

    Br J Ophthalmol. 2002 Jan;86(1):75-9. Erratum in: Br J Ophthalmol 2002 Jun;86(6):707. PMID: 11801508 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    A randomized double-masked crossover study comparing latanoprost 0.005% with unoprostone 0.12% in patients with primary open-angle glaucoma and ocular hypertension.

    Aung T, Chew PT, Yip CC, Chan YH, See JL, Khng CG, Hoh ST, Ng LH, Lee HM.

    Am J Ophthalmol. 2001 May;131(5):636-42.PMID: 11336940 [PubMed - indexed for MEDLINE]Related articles

    3.

    A double-masked, randomized clinical trial comparing latanoprost with unoprostone in patients with open-angle glaucoma or ocular hypertension.

    Susanna R Jr, Giampani J Jr, Borges AS, Vessani RM, Jordao ML.

    Ophthalmology. 2001 Feb;108(2):259-63.PMID: 11158796 [PubMed - indexed for MEDLINE]Related articles

    4.

    Comparative effects of latanoprost (Xalatan) and unoprostone (Rescula) in patients with open-angle glaucoma and suspected glaucoma.

    Sponsel WE, Paris G, Trigo Y, Pena M.

    Am J Ophthalmol. 2002 Oct;134(4):552-9.PMID: 12383812 [PubMed - indexed for MEDLINE]Related articles

    5.

    Randomized clinical trial of latanoprost and unoprostone in patients with elevated intraocular pressure.

    Jampel HD, Bacharach J, Sheu WP, Wohl LG, Solish AM, Christie W; Latanoprost/Unoprostone Study Group.

    Am J Ophthalmol. 2002 Dec;134(6):863-71.PMID: 12470755 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effects of latanoprost and unoprostone when used alone or in combination for open-angle glaucoma.

    Saito M, Takano R, Shirato S.

    Am J Ophthalmol. 2001 Oct;132(4):485-9.PMID: 11589867 [PubMed - indexed for MEDLINE]Related articles

    7.

    A comparative clinical study of latanoprost and isopropyl unoprostone in Japanese patients with primary open-angle glaucoma and ocular hypertension.

    Tsukamoto H, Mishima HK, Kitazawa Y, Araie M, Abe H, Negi A; Glaucoma Study Group.

    J Glaucoma. 2002 Dec;11(6):497-501.PMID: 12483094 [PubMed - indexed for MEDLINE]Related articles

    8.

    Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005%.

    Stewart WC, Sharpe ED, Stewart JA, Holmes KT, Latham KE.

    Am J Ophthalmol. 2001 Mar;131(3):339-44.PMID: 11239866 [PubMed - indexed for MEDLINE]Related articles

    9.

    Comparison of brimonidine with latanoprost in the adjunctive treatment of glaucoma. ALPHAGAN/XALATAN Study Group.

    Simmons ST, Samuelson TW.

    Clin Ther. 2000 Apr;22(4):388-99.PMID: 10823361 [PubMed - indexed for MEDLINE]Related articles

    10.

    The additive intraocular pressure-lowering effect of latanoprost 0.005% daily once and pilocarpine 2% t.i.d. in patients with open-angle glaucoma or ocular hypertension. a 6-month, randomized, multicenter study. German Latanoprost Study Group.

    Diestelhorst M.

    Graefes Arch Clin Exp Ophthalmol. 2000 May;238(5):433-9.PMID: 10901475 [PubMed - indexed for MEDLINE]Related articles

    11.

    Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on beta-blockers: tolerance and peak intraocular pressure lowering.

    Simmons ST, Earl ML; Alphagan/Xalatan Study Group.

    Ophthalmology. 2002 Feb;109(2):307-14; discussion 314-5.PMID: 11825814 [PubMed - indexed for MEDLINE]Related articles

    12.

    Latanoprost : an update of its use in glaucoma and ocular hypertension.

    Perry CM, McGavin JK, Culy CR, Ibbotson T.

    Drugs Aging. 2003;20(8):597-630. Review.PMID: 12795627 [PubMed - indexed for MEDLINE]Related articles

    13.

    Latanoprost or brimonidine as treatment for elevated intraocular pressure: multicenter trial in the United States.

    Camras CB, Sheu WP; United States Latanoprost-Brimonidine Study Group.

    J Glaucoma. 2005 Apr;14(2):161-7.PMID: 15741820 [PubMed - indexed for MEDLINE]Related articles

    14.

    A comparison of intraocular pressure-lowering effect of prostaglandin F2 -alpha analogues, latanoprost, and unoprostone isopropyl.

    Kobayashi H, Kobayashi K, Okinami S.

    J Glaucoma. 2001 Dec;10(6):487-92.PMID: 11740220 [PubMed - indexed for MEDLINE]Related articles

    15.

    A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma.

    Noecker RS, Dirks MS, Choplin NT, Bernstein P, Batoosingh AL, Whitcup SM; Bimatoprost/Latanoprost Study Group.

    Am J Ophthalmol. 2003 Jan;135(1):55-63.PMID: 12504698 [PubMed - indexed for MEDLINE]Related articles

    16.

    Switching from latanoprost to fixed-combination latanoprost-timolol: a 21-day, randomized, double-masked, active-control study in patients with glaucoma and ocular hypertension.

    Olander K, Zimmerman TJ, Downes N, Schoenfelder J; Xalacom/Latanoprost Study Group.

    Clin Ther. 2004 Oct;26(10):1619-29.PMID: 15598478 [PubMed - indexed for MEDLINE]Related articles

    17.

    A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.

    Topouzis F, Melamed S, Danesh-Meyer H, Wells AP, Kozobolis V, Wieland H, Andrew R, Wells D.

    Eur J Ophthalmol. 2007 Mar-Apr;17(2):183-90.PMID: 17415690 [PubMed - indexed for MEDLINE]Related articles

    18.

    A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.

    Franks WA, Renard JP, Cunliffe IA, Rojanapongpun P.

    Clin Ther. 2006 Mar;28(3):332-9.PMID: 16750448 [PubMed - indexed for MEDLINE]Related articles

    19.

    A comparison of the efficacy and tolerability of brimonidine and latanoprost in adults with open-angle glaucoma or ocular hypertension: a three-month, multicenter, randomized, double-masked, parallel-group trial.

    DuBiner HB, Mroz M, Shapiro AM, Dirks MS; Brimonidine vs. Latanoprost Study Group.

    Clin Ther. 2001 Dec;23(12):1969-83.PMID: 11813932 [PubMed - indexed for MEDLINE]Related articles

    20.

    Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.

    Netland PA, Landry T, Sullivan EK, Andrew R, Silver L, Weiner A, Mallick S, Dickerson J, Bergamini MV, Robertson SM, Davis AA; Travoprost Study Group.

    Am J Ophthalmol. 2001 Oct;132(4):472-84.PMID: 11589866 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity